SG10201501611QA - Circulation of components during microfluidization and/or homogenization emulsions - Google Patents
Circulation of components during microfluidization and/or homogenization emulsionsInfo
- Publication number
- SG10201501611QA SG10201501611QA SG10201501611QA SG10201501611QA SG10201501611QA SG 10201501611Q A SG10201501611Q A SG 10201501611QA SG 10201501611Q A SG10201501611Q A SG 10201501611QA SG 10201501611Q A SG10201501611Q A SG 10201501611QA SG 10201501611Q A SG10201501611Q A SG 10201501611QA
- Authority
- SG
- Singapore
- Prior art keywords
- homogenization
- emulsions
- circulation
- components during
- during microfluidization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/44—Mixers in which the components are pressed through slits
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
- B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
- B01F27/271—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator
- B01F27/2711—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator provided with intermeshing elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/80—Mixing plants; Combinations of mixers
- B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
- B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28351809P | 2009-12-03 | 2009-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201501611QA true SG10201501611QA (en) | 2015-04-29 |
Family
ID=43923723
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201501611QA SG10201501611QA (en) | 2009-12-03 | 2010-12-03 | Circulation of components during microfluidization and/or homogenization emulsions |
SG2012039160A SG181096A1 (en) | 2009-12-03 | 2010-12-03 | Circulation of components during microfluidization and/or homogenization emulsions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012039160A SG181096A1 (en) | 2009-12-03 | 2010-12-03 | Circulation of components during microfluidization and/or homogenization emulsions |
Country Status (23)
Country | Link |
---|---|
US (6) | USRE46441E1 (en) |
EP (3) | EP2356983B1 (en) |
JP (2) | JP5820390B2 (en) |
KR (1) | KR101523215B1 (en) |
CN (2) | CN102753149B (en) |
AU (1) | AU2010325752B2 (en) |
BR (1) | BR112012013427B8 (en) |
CA (1) | CA2782511C (en) |
DK (1) | DK2356983T3 (en) |
EA (1) | EA024770B1 (en) |
ES (2) | ES2573710T3 (en) |
HK (2) | HK1160396A1 (en) |
HR (1) | HRP20130398T1 (en) |
IL (1) | IL219984B (en) |
MX (3) | MX360299B (en) |
NZ (1) | NZ600323A (en) |
PL (1) | PL2356983T3 (en) |
PT (1) | PT2356983E (en) |
RS (1) | RS52748B (en) |
SG (2) | SG10201501611QA (en) |
SI (2) | SI2506834T1 (en) |
SM (1) | SMT201300044B (en) |
WO (1) | WO2011067673A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
ES2420829T3 (en) * | 2005-11-04 | 2013-08-27 | Novartis Vaccines And Diagnostics S.R.L. | Vaccines adjuvant with non-virion antigen prepared from influenza viruses grown in cell culture |
CN102307590A (en) | 2009-02-10 | 2012-01-04 | 诺华有限公司 | Influenza vaccines with reduced amounts of squalene |
CA2780425C (en) | 2009-12-03 | 2014-02-04 | Novartis Ag | Hydrophilic filtration during manufacture of vaccine adjuvants |
SI2506834T1 (en) | 2009-12-03 | 2016-04-29 | Novartis Ag | Circulation of components during homogenization and microfluidization of emulsions |
DE102009056884B4 (en) | 2009-12-03 | 2021-03-18 | Novartis Ag | Vaccine Adjuvants and Improved Methods for Making Same |
CL2012001399A1 (en) * | 2009-12-03 | 2013-03-08 | Novartis Ag | Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion. |
DE102009056883B4 (en) | 2009-12-03 | 2012-08-16 | Novartis Ag | Vaccine adjuvants and improved methods of making the same |
PL3489211T3 (en) | 2010-05-12 | 2020-12-14 | Novartis Ag | Improved methods for preparing squalene |
CA2866406A1 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of booster vaccines |
US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
US20150273036A1 (en) | 2012-10-12 | 2015-10-01 | Glaxosmithkline Biologicals Sa | Non-cross-linked acellular pertussis antigens for use in combination vaccines |
JP2016502994A (en) | 2012-12-18 | 2016-02-01 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Conjugates to protect against diphtheria and / or tetanus |
RU2550253C2 (en) * | 2013-06-25 | 2015-05-10 | Татьяна Владимировна Шленская | Homogeneous milk product manufacture device and method for hydration of polar molecules of milk proteins amino acids in process of homogeneous milk product preparation |
US9127542B2 (en) | 2014-01-28 | 2015-09-08 | Lawrence O. Price | Subterranean well treatment process |
EP4144369A1 (en) | 2014-09-26 | 2023-03-08 | Seqirus UK Limited | Vaccination of immunocompromised subjects |
EP3197487B1 (en) | 2014-09-26 | 2022-08-03 | Seqirus UK Limited | Vaccination of immunocompromised subjects |
EP3511020B1 (en) | 2014-12-02 | 2021-01-20 | Novartis AG | Manufacture of surfactant-containing compositions |
JP6992057B2 (en) | 2016-06-10 | 2022-01-13 | クラリティ コスメティックス インコーポレイテッド | Non-acne-forming hair and scalp care products and how to use them |
IT201800007790A1 (en) * | 2018-08-02 | 2020-02-02 | Gea Mech Equipment Italia Spa | HIGH PRESSURE HOMOGENIZER |
WO2022112191A1 (en) * | 2020-11-25 | 2022-06-02 | Univerza V Ljubljani | Liquid decontamination system comprising a cavitation device and method of decontamination of a liquid |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1876979U (en) | 1963-06-14 | 1963-08-01 | Rehau Plastiks | DRAINAGE PIPE. |
CA951238A (en) | 1970-06-10 | 1974-07-16 | Ralph R. Calaceto | Abrasion resistant venturi scrubbers |
US4060082A (en) | 1976-08-16 | 1977-11-29 | Mpl, Inc. | Dual-ingredient medication dispenser |
US4340482A (en) | 1978-02-21 | 1982-07-20 | Millipore Corporation | Process for grafting amino acid molecules onto preformed polymer surfaces and products prepared thereby |
US4473474A (en) | 1980-10-27 | 1984-09-25 | Amf Inc. | Charge modified microporous membrane, process for charge modifying said membrane and process for filtration of fluid |
US4673504A (en) | 1980-10-27 | 1987-06-16 | Cuno Inc. | Charge modified microporous membrane |
US4533254A (en) | 1981-04-17 | 1985-08-06 | Biotechnology Development Corporation | Apparatus for forming emulsions |
US4432875A (en) | 1981-05-29 | 1984-02-21 | Brunswick Corporation | Semi-permeable membranes and processes for making the same |
US4473475A (en) | 1981-05-29 | 1984-09-25 | Amf Inc. | Charge modified microporous membrane, process for charge modifying said membrane, and process for filtration of fluids |
US4413074A (en) | 1982-01-25 | 1983-11-01 | Brunswick Corporation | Hydrophilic surfaces and process for making the same |
NZ209308A (en) | 1983-08-30 | 1991-08-27 | Genentech Inc | Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein |
US4705753A (en) | 1984-06-08 | 1987-11-10 | Gregor Harry P | Biologically active acrylonitrile-based copolymeric membrane |
US4618533A (en) | 1984-11-30 | 1986-10-21 | Millipore Corporation | Porous membrane having hydrophilic surface and process |
US4794002A (en) | 1985-11-01 | 1988-12-27 | Monsanto Company | Modified polymeric surfaces and process for preparing same |
US4964990A (en) | 1987-05-20 | 1990-10-23 | Gelman Sciences, Inc. | Filtration membranes and method of making the same |
US4943374A (en) | 1988-04-21 | 1990-07-24 | Gessner & Co., Gmbh | Use of a microporous membrane constructed of polyether sulfon and hydrophilization agent for the filtration of beer |
EP0520979B1 (en) | 1988-10-17 | 1999-01-13 | Hemasure, Inc. | Process for the covalent surface modification of hydrophobic polymers and articles made therefrom |
WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
JPH06500128A (en) * | 1991-05-08 | 1994-01-06 | シュバイツ・ゼルム―・ウント・インプフィンスティテュート・ベルン | Immune stimulating and immunoenhancing reconstituted influenza virosomes and vaccines containing the same |
JPH0614756Y2 (en) | 1991-06-26 | 1994-04-20 | 株式会社アルテ | Assembled dual chamber syringe |
US5178765A (en) | 1991-09-18 | 1993-01-12 | Gelman Sciences Inc. | Hydrophilic membranes prepared from polyethersulfone/poly-2-oxazoline/polyvinylpyrrolidone blend |
CA2142103C (en) | 1992-08-28 | 2003-07-08 | Haim Aviv | Submicron emulsions as ocular drug delivery vehicles |
US5531893A (en) | 1993-02-12 | 1996-07-02 | Gelman Sciences Inc. | Inter-penetrating network charge modified microporous membrane |
US5277812A (en) | 1993-02-12 | 1994-01-11 | Gelman Sciences Inc. | Inter-penetrating network charge modified microporous membrane |
US6645463B1 (en) | 1994-05-16 | 2003-11-11 | The Board Of Regents Of The University Of Michigan | Blood-pool selective carrier for lipophilic imaging agents |
EP0770422B1 (en) | 1994-06-20 | 2002-09-04 | Nippon Shinyaku Company, Limited | Emulsion manufacturing method of emulsifier |
US5487965A (en) | 1994-09-06 | 1996-01-30 | Xerox Corporation | Processes for the preparation of developer compositions |
US5496284A (en) | 1994-09-27 | 1996-03-05 | Waldenburg; Ottfried | Dual-chamber syringe & method |
US5510118A (en) * | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
DE19542499A1 (en) | 1995-11-15 | 1997-05-22 | Bayer Ag | Method and device for producing a parenteral drug preparation |
DE19612966B4 (en) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK cells and methods of propagating influenza viruses |
AU3186297A (en) | 1996-07-05 | 1998-02-02 | Debiotech S.A. | Dual-chamber syringe for mixing two substances prior to injection |
US6168718B1 (en) | 1996-11-08 | 2001-01-02 | Pall Corporation | Method for purifying blood plasma and apparatus suitable therefor |
DE69729741T2 (en) | 1996-11-12 | 2005-07-07 | Whatman Inc., Cleveland | HYDROPHILIC POLYMERMEMBRANE FOR PHASE REVERSE |
US5971953A (en) | 1998-01-09 | 1999-10-26 | Bachynsky; Nicholas | Dual chamber syringe apparatus |
AU9785598A (en) | 1997-10-03 | 1999-04-27 | Texas Pharmaceuticals, Inc. | Improved dual chamber syringe apparatus |
US6039872A (en) | 1997-10-27 | 2000-03-21 | Pall Corporation | Hydrophilic membrane |
JP4117106B2 (en) | 1998-03-30 | 2008-07-16 | 株式会社荏原製作所 | Method and apparatus for treating manganese-containing water |
GB9808689D0 (en) | 1998-04-23 | 1998-06-24 | Kalsep Ltd | Improved membrane |
JP3995830B2 (en) | 1999-01-13 | 2007-10-24 | 富士フイルム株式会社 | Thermally developed image recording material |
US6193077B1 (en) | 1999-02-08 | 2001-02-27 | Osmonics, Inc. | Non-cracking hydrophilic polyethersulfone membranes |
CA2689696C (en) | 1999-02-26 | 2013-08-06 | Novartis Vaccines And Diagnostics, Inc. | Microemulsions with adsorbed macromolecules and microparticles |
KR100310234B1 (en) | 1999-08-20 | 2001-11-14 | 안복현 | Preparation method of metal oxide slurry for cmp of semiconductor |
GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
DE10059430A1 (en) | 2000-11-30 | 2002-06-06 | Cognis Deutschland Gmbh | Finely divided emulsions |
MY134424A (en) | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
US20060148776A1 (en) | 2003-03-13 | 2006-07-06 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
PT1613346E (en) * | 2003-04-04 | 2013-01-29 | Pah Usa 15 Llc | Microfluidized oil-in-water emulsions and vaccine compositions |
US20050208083A1 (en) * | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
WO2005027872A2 (en) | 2003-06-04 | 2005-03-31 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
JP5003155B2 (en) | 2004-03-23 | 2012-08-15 | ニプロ株式会社 | Prefilled syringe |
GB0406515D0 (en) * | 2004-03-23 | 2004-04-28 | Novartis Ag | Organic compounds |
AU2005224030B2 (en) | 2004-03-23 | 2008-09-25 | Novartis Ag | Pharmaceutical compositions |
JP5393978B2 (en) | 2004-04-05 | 2014-01-22 | ゾエティス・ピー・エルエルシー | Microfluidized oil-in-water emulsion and vaccine composition |
GB0411411D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxosmithkline Biolog Sa | Vaccines |
DE102004031550A1 (en) | 2004-06-29 | 2006-02-02 | Cognis Ip Management Gmbh | Highly concentrated, self-emulsifying emulsion bases for the preparation of oil-in-water emulsions |
GB0416120D0 (en) | 2004-07-19 | 2004-08-18 | Health Prot Agency | Stable compositions containing OMV's |
US7537718B2 (en) | 2004-10-13 | 2009-05-26 | 3M Innovative Properties Company | Hydrophilic polyethersulfone membrane and method for preparing same |
TW200611880A (en) | 2004-10-14 | 2006-04-16 | Bi-Chang Li | The microprocessor unit of bio-sludge-hydrolyzing equipment |
EP1809238B1 (en) | 2004-11-09 | 2008-10-29 | Novagali Pharma SA | Ophthalmic emulsions containing an immunosuppressive agent |
GB0427568D0 (en) | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
PT1861120T (en) | 2005-03-23 | 2016-08-18 | Glaxosmithkline Biologicals Sa | Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response |
US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
US20070036831A1 (en) | 2005-08-09 | 2007-02-15 | Nanobio Corporation | Nanoemulsion compositions having anti-inflammatory activity |
DK1945271T3 (en) | 2005-10-24 | 2020-01-13 | Magsense Life Sciences Inc | Process for the preparation of polymer-coated microparticles |
EA014190B1 (en) * | 2005-11-04 | 2010-10-29 | Новартис Вэксинс Энд Диагностикс Срл | Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
NZ594482A (en) | 2005-11-04 | 2012-11-30 | Novartis Vaccines & Diagnostic | Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant |
FR2896162B1 (en) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | EMULSION OIL IN THERMOREVERSIBLE WATER |
EP1988918A4 (en) * | 2006-02-22 | 2010-04-28 | Novavax Inc | Adjuvant and vaccine compositions |
EP1849452A1 (en) | 2006-04-27 | 2007-10-31 | Cognis IP Management GmbH | Dispersions containing acylglutamate |
CN105727276A (en) | 2006-07-17 | 2016-07-06 | 葛兰素史密丝克莱恩生物有限公司 | Influenza vaccine |
GB0622282D0 (en) | 2006-11-08 | 2006-12-20 | Novartis Ag | Quality control methods |
US20110045022A1 (en) | 2006-12-06 | 2011-02-24 | Theodore Tsai | Vaccines including antigen from four strains of influenza virus |
US8506966B2 (en) | 2008-02-22 | 2013-08-13 | Novartis Ag | Adjuvanted influenza vaccines for pediatric use |
AU2008354007A1 (en) | 2008-04-04 | 2009-10-08 | Robert Rodriguez | Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents |
US8187554B2 (en) | 2008-04-23 | 2012-05-29 | Microfluidics International Corporation | Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems |
US8771746B2 (en) * | 2008-06-19 | 2014-07-08 | Otonomy, Inc. | Colloidal suspensions comprising a therapeutic agent and squalene |
SI2506834T1 (en) | 2009-12-03 | 2016-04-29 | Novartis Ag | Circulation of components during homogenization and microfluidization of emulsions |
CA2780425C (en) | 2009-12-03 | 2014-02-04 | Novartis Ag | Hydrophilic filtration during manufacture of vaccine adjuvants |
US20130189311A1 (en) | 2009-12-03 | 2013-07-25 | Novartis Ag | Arranging interaction and back pressure chambers for microfluidization |
DE102009056884B4 (en) | 2009-12-03 | 2021-03-18 | Novartis Ag | Vaccine Adjuvants and Improved Methods for Making Same |
CL2012001399A1 (en) * | 2009-12-03 | 2013-03-08 | Novartis Ag | Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion. |
DE102009056883B4 (en) * | 2009-12-03 | 2012-08-16 | Novartis Ag | Vaccine adjuvants and improved methods of making the same |
DE102009056871A1 (en) | 2009-12-03 | 2011-06-22 | Novartis AG, 4056 | Vaccine adjuvants and improved methods of making the same |
WO2011106565A1 (en) | 2010-02-24 | 2011-09-01 | Travers William A | Methods and devices for controlling particle size and particle size distribution |
GB201009671D0 (en) * | 2010-06-10 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel process |
-
2010
- 2010-12-03 SI SI201031149T patent/SI2506834T1/en unknown
- 2010-12-03 WO PCT/IB2010/003394 patent/WO2011067673A2/en active Application Filing
- 2010-12-03 EP EP10252043A patent/EP2356983B1/en not_active Revoked
- 2010-12-03 NZ NZ600323A patent/NZ600323A/en unknown
- 2010-12-03 CN CN201080062766.2A patent/CN102753149B/en active Active
- 2010-12-03 SG SG10201501611QA patent/SG10201501611QA/en unknown
- 2010-12-03 PL PL10252043T patent/PL2356983T3/en unknown
- 2010-12-03 RS RS20130158A patent/RS52748B/en unknown
- 2010-12-03 CN CN201510552611.1A patent/CN105055311A/en active Pending
- 2010-12-03 JP JP2012541596A patent/JP5820390B2/en active Active
- 2010-12-03 MX MX2014014450A patent/MX360299B/en unknown
- 2010-12-03 SI SI201030181T patent/SI2356983T1/en unknown
- 2010-12-03 SG SG2012039160A patent/SG181096A1/en unknown
- 2010-12-03 AU AU2010325752A patent/AU2010325752B2/en active Active
- 2010-12-03 PT PT102520434T patent/PT2356983E/en unknown
- 2010-12-03 ES ES10812803.4T patent/ES2573710T3/en active Active
- 2010-12-03 MX MX2012006216A patent/MX2012006216A/en active IP Right Grant
- 2010-12-03 US US14/881,410 patent/USRE46441E1/en active Active
- 2010-12-03 BR BR112012013427A patent/BR112012013427B8/en active IP Right Grant
- 2010-12-03 ES ES10252043T patent/ES2402569T3/en active Active
- 2010-12-03 EA EA201290426A patent/EA024770B1/en not_active IP Right Cessation
- 2010-12-03 EP EP10812803.4A patent/EP2506834B1/en active Active
- 2010-12-03 KR KR1020127017218A patent/KR101523215B1/en active IP Right Grant
- 2010-12-03 EP EP13155782.9A patent/EP2638895B1/en active Active
- 2010-12-03 DK DK10252043.4T patent/DK2356983T3/en active
- 2010-12-03 US US13/513,564 patent/US8895629B2/en not_active Ceased
- 2010-12-03 CA CA2782511A patent/CA2782511C/en active Active
- 2010-12-03 MX MX2014014449A patent/MX344381B/en unknown
-
2012
- 2012-02-01 HK HK12100892.5A patent/HK1160396A1/en unknown
- 2012-05-24 IL IL219984A patent/IL219984B/en active IP Right Grant
-
2013
- 2013-03-05 HK HK13102698.6A patent/HK1175404A1/en unknown
- 2013-04-17 SM SM201300044T patent/SMT201300044B/en unknown
- 2013-05-07 HR HRP20130398AT patent/HRP20130398T1/en unknown
-
2014
- 2014-09-05 US US14/478,864 patent/US20160113870A1/en not_active Abandoned
- 2014-09-05 US US14/478,818 patent/US9750690B2/en active Active
-
2015
- 2015-07-29 JP JP2015149196A patent/JP2015193656A/en active Pending
-
2017
- 2017-06-26 US US15/632,562 patent/US10463615B2/en active Active
-
2019
- 2019-09-16 US US16/571,813 patent/US11141376B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201501611QA (en) | Circulation of components during microfluidization and/or homogenization emulsions | |
IL215516A0 (en) | Emulsions of perfluorocarbons | |
BRPI1014864A2 (en) | "implantation of spinous processes and associated methods" | |
EP2635185A4 (en) | Determination of tissue oxygenation in vivo | |
GB0922332D0 (en) | Method of treatment and screening method | |
EP2493309A4 (en) | Methods of treating or preventing acute erythema | |
IL214664A0 (en) | Methods of treating hair related conditions | |
EP2544655A4 (en) | Compositions and methods for treating skin | |
HK1164155A1 (en) | Water-in-oil emulsion composition | |
EP2846716A4 (en) | Implant for fixation of first and second bones and method of fixing first and second bones using the implant | |
HRP20190162T1 (en) | Selection and use of lactic acid bacteria preventing bone loss in mammals | |
EP2667766A4 (en) | Method for combined imaging and treating organs and tissues | |
IL197655A0 (en) | Emulsions and methods of their production | |
ZA201303222B (en) | Composition and method for treating skin conditions | |
EP2640408A4 (en) | Keratin compositions for treatment of bone deficiency or injury | |
HK1204545A1 (en) | Compositions and methods for the treatment of bone voids and open fractures | |
BR112013008717A2 (en) | unit and method of milk emulsification | |
HK1157228A1 (en) | Compositions and methods of treating amyloid disease | |
ZA201105179B (en) | Selection of animals for desired milk and/or tissue profile | |
GB0919837D0 (en) | Method of treatment and screening method | |
HRP20170170T1 (en) | Oil-in-water emulsion of mometasone | |
GB0808326D0 (en) | Compositions and methods for the treatment of fybromyalgia | |
ZA201005770B (en) | The treatment of damaged skin | |
EP2515830A4 (en) | Compositions and methods for increasing cellular fat and bleaching skin | |
GB0901175D0 (en) | The treatment of skin aging |